YDES vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

YDES

48.7
AI Score
VS
YDES Wins

CBIO

43.4
AI Score

Investment Advisor Scores

YDES

49score
Recommendation
HOLD

CBIO

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric YDES CBIO Winner
Revenue 596,817 10.84M CBIO
Net Income -8.31M 153,942 CBIO
Net Margin -1392.6% 1.4% CBIO
Operating Income -5.27M -152.63M YDES
ROE 291.0% 0.1% YDES
ROA -60.3% 0.1% CBIO
Total Assets 13.78M 240.29M CBIO
Cash 6.01M 213.19M CBIO
Current Ratio 5.88 6.56 CBIO
Free Cash Flow -8.04M -72.45M YDES

Relative Price Performance (Last 90 Days)

YDES 1M: -0.9% · 3M: -53.8% CBIO 1M: -3.4% · 3M: -8.6%

Current Technical Phase

YDES

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.4 · Price: $2.32

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.2 · Price: $16.38

Fundamentals Snapshot

Metric YDES CBIO
Market Cap
Forward P/E 0.0 -6.2
Trailing P/E
Revenue (TTM)
Revenue Growth 1.0% 0.0%
Gross Margin 0.3% 1.0%
Operating Margin -4.4% -14.3%
EPS -0.12 -0.14
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, YDES is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.